1    2    3    4   
Press Releases
Oct 01, 2015
Generex Announces Issuance of Buccal Cannabis White Paper
Sep 30, 2015
Generex Announces Agreement to Acquire Equity Interest in Hema Diagnostic Systems
Sep 08, 2015
Generex Announces Commencement of Buccal Leuprolide R&D Work
All releases
Webcast Events and Media

Print Print     Email Email page

Investor Home

Investor Relations

For more information please contact:
Todd Falls
Tel: 1-800-391-6755
Fax: (647) 547-7104


OTC Bulletin Board

Listed Security

GNBT Common Stock

Transfer Agent

StockTrans, Inc.
44 West Lancaster Avenue
Ardmore, PA 19003
Phone 610-649-7300
Fax 610-649-7302

Corporate Counsel

Eckert Seamans Cherin & Mellott, LLC
1515 Market Street, 9th Floor
Philadelphia, PA 19102
Phone 215-851-8447
Fax 215-851-8383

Stock Quote
OTC BB: GNBT        0.01
2 Oct 2015    3:08 PM ET
Investor Tool Kit
PDF Corporate Fact Sheet
PDF Investor Presentation

Privacy Policy